Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination. / Straten, Per Thor; Andersen, Mads Hald.

I: Vaccine, Bind 29, Nr. 21, 12.05.2011, s. 3728.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Straten, PT & Andersen, MH 2011, 'Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination', Vaccine, bind 29, nr. 21, s. 3728. https://doi.org/10.1016/j.vaccine.2011.03.007, https://doi.org/10.1016/j.vaccine.2011.03.007

APA

Straten, P. T., & Andersen, M. H. (2011). Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination. Vaccine, 29(21), 3728. https://doi.org/10.1016/j.vaccine.2011.03.007, https://doi.org/10.1016/j.vaccine.2011.03.007

Vancouver

Straten PT, Andersen MH. Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination. Vaccine. 2011 maj 12;29(21):3728. https://doi.org/10.1016/j.vaccine.2011.03.007, https://doi.org/10.1016/j.vaccine.2011.03.007

Author

Straten, Per Thor ; Andersen, Mads Hald. / Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination. I: Vaccine. 2011 ; Bind 29, Nr. 21. s. 3728.

Bibtex

@article{057270d5e5de44b2b4de3f21e22e3dd3,
title = "Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination",
author = "Straten, {Per Thor} and Andersen, {Mads Hald}",
year = "2011",
month = may,
day = "12",
doi = "10.1016/j.vaccine.2011.03.007",
language = "English",
volume = "29",
pages = "3728",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier",
number = "21",

}

RIS

TY - JOUR

T1 - Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination

AU - Straten, Per Thor

AU - Andersen, Mads Hald

PY - 2011/5/12

Y1 - 2011/5/12

U2 - 10.1016/j.vaccine.2011.03.007

DO - 10.1016/j.vaccine.2011.03.007

M3 - Journal article

C2 - 21420415

VL - 29

SP - 3728

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 21

ER -

ID: 40222742